Value through Innovation27 July 2016

Clinical Study Results

  • VARGATEF ® - Mesothelioma
    Clinical Study Number 1199.93
    Study Indication Mesothelioma
    Product VARGATEF ®
    Generic Name Nintedanib
    Lab Code
    Clinical Phase II/III
    Study Title

    LUME-Meso: Double blind, randomised, multicentre, phase II/III study of nintedanib in combination with pemetrexed/cisplatin followed by continuing nintedanib monotherapy vs. placebo in combination with pemetrexed/cisplatin followed by continuing placebo monotherapy for the treatment of patients with unresectable malignant pleural mesothelioma

    Study Document Trial synopsis1199.93 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.